Here are three things to know:
1. Dr. Marc Tewfik, MUHC’s director of rhinology, has already performed many surgeries using Scopis technology.
2. The combined technology allows surgeons to establish safely tested pathways based on pre-surgical plans.
3. Scopis’ solutions are intended to cut operating time and improve clinical outcomes.
More articles on devices:
Hyalex Orthopaedics raises $16M — Appoints new CEO, board members
DJO Global names Jeffery McCaulley global president of DJO Surgical — 3 insights
Former NFL quarterback’s neuromonitoring company begins trading publicly: 6 notes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
